Abstract
A patient is described with quinidine-induced acute lymphadenopathy syndrome proven by rechallenge of the drug. Serum markers for systemic lupus were negative.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abratt R. P., Sealy R., Uys C. J., Lawson R. Lymphadenopathy associated with diphenylhydantoin therapy. Clin Oncol. 1982 Dec;8(4):351–356. [PubMed] [Google Scholar]
- Gams R. A., Neal J. A., Conrad F. G. Hydantoin-induced pseudo-pseudolymphoma. Ann Intern Med. 1968 Sep;69(3):557–568. doi: 10.7326/0003-4819-69-3-557. [DOI] [PubMed] [Google Scholar]
- Gay R. G., Fielder K. L., Grogan T. M. Quinidine-induced reactive lymphadenopathy. Am J Med. 1987 Jan;82(1):143–145. doi: 10.1016/0002-9343(87)90392-5. [DOI] [PubMed] [Google Scholar]
- Harris N. L., Widder D. J. Phenytoin and generalized lymphadenopathy. Arch Pathol Lab Med. 1983 Dec;107(12):663–664. [PubMed] [Google Scholar]
- Lavie C. J., Biundo J., Quinet R. J., Waxman J. Systemic lupus erythematosus (SLE) induced by quinidine. Arch Intern Med. 1985 Mar;145(3):446–448. [PubMed] [Google Scholar]
- McGrath H., Jr Quinidine-induced reactive lymphadenopathy. Am J Med. 1987 Aug;83(2):369–369. [PubMed] [Google Scholar]
- Schwinghammer T. L., Howrie D. L. Phenytoin-induced lymphadenopathy. Drug Intell Clin Pharm. 1983 Jun;17(6):460–462. doi: 10.1177/106002808301700608. [DOI] [PubMed] [Google Scholar]
- West S. G., McMahon M., Portanova J. P. Quinidine-induced lupus erythematosus. Ann Intern Med. 1984 Jun;100(6):840–842. doi: 10.7326/0003-4819-100-6-840. [DOI] [PubMed] [Google Scholar]